Clinical Trials Logo
  1. Home
  2. Blood Cancer
  3. NCT00186225

Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors

Blood Cancer Clinical Trial

Official title:
Stem Cell Transplantation From Matched Unrelated or Partially Matched Related Donors Using a Preparatory Regimen Consisting of Fractionated Total Body Irradiation (FTBI) and Cyclophosphamide (CY)

Clinical Trial Summary

To evaluate the use of unrelated donors for hematopoietic cell transplantation in the treatment of hematologic and lymphoid malignancies.

Clinical Trial Description

Stem Cell Transplantation from Matched Unrelated or Partially Matched Related Donors Using a Preparatory Regimen Consisting of Fractionated Total Body Irradiation (FTBI) and Cyclophosphamide (CY). To administer high dose radio-chemotherapy followed by stem cell transplantation from a matched unrelated donor or a partially matched related donor. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00186225
Study type Interventional
Source Stanford University
Contact
Status Completed
Phase N/A
Start date November 1989
Completion date May 2010
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04188678 - Resiliency in Older Adults Undergoing Bone Marrow Transplant N/A
Not yet recruiting NCT06455592 - Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years N/A
Completed NCT03654404 - A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients N/A
Recruiting NCT06116032 - Immune Profiling for Cancer Immunotherapy Response
Recruiting NCT04955938 - A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms Phase 1
Recruiting NCT06119685 - IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers Phase 1/Phase 2
Not yet recruiting NCT05391490 - Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies Phase 1
Not yet recruiting NCT06469307 - Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
Recruiting NCT05709522 - Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients
Active, not recruiting NCT05147311 - Positive Psychology Intervention In HSCT N/A
Recruiting NCT04372524 - Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
Completed NCT01957579 - A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies Phase 1
Completed NCT00185640 - Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies Phase 2
Withdrawn NCT04390542 - Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy N/A
Completed NCT04419623 - A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer Phase 1
Recruiting NCT04806295 - The Leukemia and Lymphoma Society (LLS) National Research Registry
Recruiting NCT05873205 - Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation Phase 2
Completed NCT00962494 - Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors Phase 2
Completed NCT00185796 - TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD Phase 2
Completed NCT04236063 - Rehabilitation Needs of the Malaysian Haematological Cancer Survivors